Sienna Biopharmaceuticals (SNNAQ) Short Interest Ratio & Short Volume

Short interest is the volume of Sienna Biopharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 31st, investors have sold 1,000 shares of SNNAQ short. 0.00% of Sienna Biopharmaceuticals' shares are currently sold short. Learn More on Sienna Biopharmaceuticals' current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of Sienna Biopharmaceuticals' floating shares are currently sold short.

0.00% of Sienna Biopharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Sienna Biopharmaceuticals: Evelo Biosciences, Inc. (0.04%), Comera Life Sciences Holdings, Inc. (0.02%), Genocea Biosciences, Inc. (0.33%), American Bio Medica Co. (0.00%), Aridis Pharmaceuticals, Inc. (0.00%), Statera Biopharma, Inc. (0.15%), Ampio Pharmaceuticals, Inc. (0.01%), Smart for Life, Inc. (0.01%), Clever Leaves Holdings Inc. (0.52%), OncoSec Medical Incorporated (0.00%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks.

Short selling SNNAQ is an investing strategy that aims to generate trading profit from Sienna Biopharmaceuticals as its price is falling. SNNAQ shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Sienna Biopharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SNNAQ, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNNAQ, twice per month. The most recent reporting period available is May, 31 2025.